Business Emerald Health posts 32% sales drop, exits cannabis sector After too-bleak an outlook in legal weed, the firm says it can better secure shareholder value via pharmaceutical development Nick LabaNovember 30, 2021
Business Numinus develops in-house tests to detect compounds in psychedelic mushrooms The methods will be available as part of third-party client services Nick LabaNovember 29, 2021
Business Flowr Corp posts $9.2M loss in Q3 The firm says opportunities lie in new genetics and its EU GMP-certified operations in Portugal Nick LabaNovember 29, 2021
Business Fire & Flower consolidating shares for Nasdaq listing Each shareholder's ownership in the firm and proportional voting power remains the same Kathryn TindaleNovember 29, 2021
Business Greenway makes adjusted EBITDA profit in first reported quarter Early feedback on the firm's cannabis products has been strong Nick LabaNovember 26, 2021
Business MTL Cannabis RTO of Canada House to close early 2022 The Montreal-based producer will have access to additional cultivation space, more than doubling annual production capacity Kathryn TindaleNovember 26, 2021
Business TGOD’s Q3 revenue drops 23% TGOD says new acquisitions and marketing partnerships will help boost sales Natalia Buendia CalvilloNovember 25, 2021
Business Losses mount for Planet 13 in Q3 Company executives say the quarter was important for securing future growth Nick LabaNovember 24, 2021
Business First firm could commercialize hemp in Mexico if injunction approved next week A subsidiary of Xebra Brands has been challenging prohibition in lower courts for 3 years Natalia Buendia CalvilloNovember 24, 2021
Business Organigram shares rise on 22% revenue boost The firm's new CEO looks to be off to a strong start Nick LabaNovember 23, 2021